Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $129.08 million. The enterprise value is $202.24 million.
Important Dates
The next confirmed earnings date is Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 70.73 million shares outstanding. The number of shares has increased by 14.90% in one year.
| Current Share Class | 70.73M |
| Shares Outstanding | 70.73M |
| Shares Change (YoY) | +14.90% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 4.50% |
| Owned by Institutions (%) | 75.27% |
| Float | 59.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.20 |
| PS Ratio | 0.38 |
| Forward PS | 0.40 |
| PB Ratio | 0.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.88 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.04 |
Financial Efficiency
Return on equity (ROE) is -31.33% and return on invested capital (ROIC) is -5.43%.
| Return on Equity (ROE) | -31.33% |
| Return on Assets (ROA) | -4.74% |
| Return on Invested Capital (ROIC) | -5.43% |
| Return on Capital Employed (ROCE) | -10.64% |
| Weighted Average Cost of Capital (WACC) | 12.82% |
| Revenue Per Employee | $210,709 |
| Profits Per Employee | -$71,748 |
| Employee Count | 1,500 |
| Asset Turnover | 0.45 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $962,000 in taxes.
| Income Tax | 962,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.17% in the last 52 weeks. The beta is 1.78, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -63.17% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 3.00 |
| Relative Strength Index (RSI) | 37.65 |
| Average Volume (20 Days) | 1,096,205 |
Short Selling Information
The latest short interest is 5.72 million, so 8.08% of the outstanding shares have been sold short.
| Short Interest | 5.72M |
| Short Previous Month | 5.00M |
| Short % of Shares Out | 8.08% |
| Short % of Float | 9.63% |
| Short Ratio (days to cover) | 7.57 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $316.06 million and -$107.62 million in losses. Loss per share was -$1.59.
| Revenue | 316.06M |
| Gross Profit | 150.11M |
| Operating Income | -53.13M |
| Pretax Income | -106.66M |
| Net Income | -107.62M |
| EBITDA | -16.85M |
| EBIT | -53.13M |
| Loss Per Share | -$1.59 |
Full Income StatementBalance Sheet
The company has $91.54 million in cash and $172.12 million in debt, with a net cash position of -$80.58 million or -$1.14 per share.
| Cash & Cash Equivalents | 91.54M |
| Total Debt | 172.12M |
| Net Cash | -80.58M |
| Net Cash Per Share | -$1.14 |
| Equity (Book Value) | 331.92M |
| Book Value Per Share | 4.70 |
| Working Capital | 77.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.71 million and capital expenditures -$1.11 million, giving a free cash flow of -$13.82 million.
| Operating Cash Flow | -12.71M |
| Capital Expenditures | -1.11M |
| Free Cash Flow | -13.82M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
Gross margin is 47.49%, with operating and profit margins of -16.81% and -34.05%.
| Gross Margin | 47.49% |
| Operating Margin | -16.81% |
| Pretax Margin | -33.75% |
| Profit Margin | -34.05% |
| EBITDA Margin | -5.33% |
| EBIT Margin | -16.81% |
| FCF Margin | n/a |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.90% |
| Shareholder Yield | -14.90% |
| Earnings Yield | -88.46% |
| FCF Yield | -11.36% |
Analyst Forecast
The average price target for Health Catalyst is $4.06, which is 122.47% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.06 |
| Price Target Difference | 122.47% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 1.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -1.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.85 |
| Piotroski F-Score | 4 |
